BON - Company ID 0001816815
Bon Natural Life Ltd trades as BON. In its fiscal 2025 annual report the company posted revenue of $18.67M, down 21.7% from the prior year and net income of -$1.99M. This page tracks Bon Natural Life Ltd through 151 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 6 fiscal years Bon Natural Life Ltd's revenue grew from $16.40M to $18.67M, a compound annual growth rate of 2.2%. Net profit margin compressed from 15.7% to -10.7% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| New insider ownership | 3 | 2026-05-15 |
| New insider ownership | 3 | 2026-04-23 |
| New insider ownership | 3 | 2026-04-10 |
| New insider ownership | 3 | 2026-04-10 |
| New insider ownership | 3 | 2026-04-10 |
| New insider ownership | 3 | 2026-04-10 |
| New insider ownership | 3 | 2026-04-10 |
| New insider ownership | 3 | 2026-04-10 |
The largest companies sharing Bon Natural Life Ltd's SEC industry classification (medicinal chemicals & botanical products).
Bon Natural Life Ltd reported revenue of $18.67M for fiscal year 2025, a decrease of 21.7% year over year.
In its latest fiscal year Bon Natural Life Ltd reported a net loss of $1.99M.